Mycophenolate: Better value through monitoring?

Transplantation

Volumn 81, Issue 4, 2006, Pages 507-508

  Tredger, J Michael ^a   Brown, Nigel W ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; COLESTYRAMINE; CYCLOSPORIN; GANCICLOVIR; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; SALICYLIC ACID; TSUKUBAENOLIDE; WARFARIN;

AREA UNDER THE CURVE; AUTOIMMUNITY; BONE MARROW TRANSPLANTATION; COST EFFECTIVENESS ANALYSIS; DRUG ABSORPTION; DRUG EFFICACY; DRUG FORMULATION; DRUG METABOLISM; DRUG MONITORING; GASTROINTESTINAL DISEASE; GENETIC VARIABILITY; GRAFT REJECTION; HOSPITALIZATION; HUMAN; HYDROLYSIS; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; LEUKOPENIA; LIQUID CHROMATOGRAPHY; LIVER TRANSPLANTATION; MASS SPECTROMETRY; NOTE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROMOTER REGION; VALIDATION PROCESS;

DRUG MONITORING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MYCOPHENOLIC ACID; PREDNISONE;

EID: 33644622348     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000200308.21816.53     Document Type: Note

References (5)

1. Mercé B, Cirera I, Martorell J, et al. Sequential determination of pharmacokinetics and pharmacodynamics of mycophenolate mofetil in liver transplant recipients. Transplantation 2006; 81: 541.
2. van Gelder T, Shaw LM. The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantation. Transplantation 2005; 80(Suppl 2): S244.
3. Tredger JM, Brown NW, Adams J, et al. Monitoring mycophenolate in liver transplant recipients: towards a therapeutic range. Liver Transplant 2004; 10: 492.
4. Kuypers DRJ, Naesens M, Vermeire S, Vanrenterghem Y. The impact of uridine diphosphate-glucuronyltransferase 1A9 (UGT1A9) gene promoter region single-nucleotide polymorphisms T-275A and C-2152T on early mycophenolic acid dose-interval exposure in de novo renal allograft recipients. Clin Pharmacol Ther 2005; 78: 351.
5. Holt DW, Armstrong VW, Griesmacher A, et al. International federation of clinical chemistry / international association of therapeutic drug monitoring and clinical toxicology working group on immunosuppressive drug monitoring. Ther Drug Monit 2002; 24: 59.